What is Chagas Disease?
Chagas disease is a parasitic infection caused by Trypanosoma cruzi, first identified in 1909 by Carlos Chagas. It remains a significant public health concern, with an estimated 8 million people infected globally and over 12,000 deaths reported annually.
The disease is predominantly endemic in South America, Central America, and Mexico, reflecting its strong geographic association with Latin America. However, sporadic cases have also been identified in the southern United States, indicating a limited but notable spread beyond its traditional endemic regions.
What is the cause of Chagas Disease?
Chagas disease is caused by the parasite Trypanosoma cruzi, which is transmitted through contact with the feces of infected triatomine insects, commonly referred to as “kissing bugs.” These vectors typically inhabit cracks in walls and roofs of poorly constructed housing made from materials such as mud, straw, or palm thatch. Their close association with substandard living conditions facilitates human exposure, making environmental and housing factors critical in disease transmission.
Symptoms of Chagas Disease
Chagas disease progresses through two distinct clinical stages—acute and chronic—both of which may remain asymptomatic in some individuals, while others develop significant complications over time.
Acute phase (weeks to months):
Often mild or asymptomatic, but when present, symptoms may include:
- Swelling at the infection site
- Fever
- Tiredness
- Rash
- Body aches
- Eyelid swelling
- Headache
- Loss of appetite
- Nausea, diarrhea, or vomiting
- Swollen glands
- Enlarged liver or spleen
Chronic phase (long-term):
Typically asymptomatic for years or lifelong; however, approximately 20–30% of individuals develop serious complications, including:
- Cardiac manifestations: enlarged heart, heart failure, abnormal heart rhythm, or sudden death
- Gastrointestinal complications: enlarged esophagus or colon, causing difficulty in swallowing or bowel movements
Overall, while early-stage disease is often mild, the chronic phase carries a substantial risk of severe, life-altering outcomes.
Diagnostics and Treatment of Chagas Disease
Chagas disease diagnosis relies on confirmation through laboratory testing, typically using a blood sample assessed by a healthcare provider.
Treatment is most effective in the early (acute) phase, where antiparasitic medications such as Benznidazole and Nifurtimox can eliminate the parasite and achieve cure, including in congenital cases.
In the chronic phase, these treatments are no longer curative but may help delay disease progression and reduce the risk of severe complications. Their use in adults requires careful consideration due to prolonged treatment duration and potential adverse effects. In advanced chronic stages, particularly when cardiac or gastrointestinal complications develop, management typically involves long-term medical care and, in some cases, surgical intervention.
References
https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis)
https://www.mayoclinic.org/diseases-conditions/chagas-disease/symptoms-causes/syc-20356212
https://www.cdc.gov/chagas/about/index.html
Ryan Winters, Tina Nguyen, & Muhammad Waseem. (2025). Chagas disease. In StatPearls. StatPearls Publishing. Retrieved from NCBI Bookshelf.